Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

28.81
+1.304.73%
Post-market: 28.860.0500+0.17%19:59 EDT
Volume:11.98M
Turnover:345.20M
Market Cap:6.72B
PE:-46.24
High:29.44
Open:27.38
Low:27.14
Close:27.51
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:213.68M
Volume Ratio:1.54
T/O Rate:5.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:20.74
PE(LYR):56.24

Loading ...

FDA Advisers Back First Four of Seven Unapproved Peptides Under Review for Looser Rules

Reuters
·
Jul 24

Why Is Hims & Hers Health Stock Surging on Thursday?

Benzinga
·
Jul 24

Hims Gains After FDA Panel Votes to Place Popularly Used Peptide Bpc-157 on Compounding List

Reuters
·
Jul 24

Hims & Hers Health Shares up 10% After FDA Advisory Panel Votes to Place Bpc-157 Peptide on Allowed Pharmacy Compounding List

THOMSON REUTERS
·
Jul 24

Movement Alert|Hims & Hers Health Inc. Rises 6.69% in Regular Trading, FDA Peptide Drug Access Advocacy Gains Market Approval

Market Focus
·
Jul 24

Hims & Hers Shares up 2% After Telehealth Firm Urged FDA to Broaden Access to Some Peptides in Panel Meeting

THOMSON REUTERS
·
Jul 23

Peptides Could Soon Become Widely Available in the U.S. Here's What Happens Next.

Dow Jones
·
Jul 23

Hims & Hers Health Inc : Citigroup Raises Target Price to $35 from $28

THOMSON REUTERS
·
Jul 23

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares Valued at $229,075.99

Reuters
·
Jul 21

Trump's FDA May Soon Back Peptides. Should You Buy In?

Dow Jones
·
Jul 18

Hims & Hers Accounting Chief Exits

Dow Jones
·
Jul 18

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

THOMSON REUTERS
·
Jul 18

Movement Alert|Hims & Hers Health Falls 5.05% in Regular Trading, Trading at $32.87

Market Focus
·
Jul 17

Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 9.35%

TIPRANKS
·
Jul 17

Movement Alert|Hims & Hers Health Declines 5.3% in Regular Trading, Trading at $36.04

Market Focus
·
Jul 16

Movement Alert|Hims & Hers Health Rises 5.26% in Regular Trading, Trading at $36.85

Market Focus
·
Jul 15

Press Release: Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

Dow Jones
·
Jul 14

Hims & Hers Sets Second-quarter Results Release and Investor Call

Reuters
·
Jul 14

Movement Alert|Hims & Hers Health Falls 5.36% in Regular Trading, Insider Selling Filings Add to Ongoing Fundamental Pressure

Market Focus
·
Jul 10

Hims & Hers's Peptide Opportunity Remains in Focus

Dow Jones
·
Jul 10